Participated · Series B · Feb 2026

HiJoJo Partners is an independent asset-management company established in 2017 by Spiridon Menzas that specializes in assembling and distributing "target funds" investing in U.S. and other global unicorns. Through both online and offline channels it has sold more than ¥500 billion worth of funds to Japanese investors as of 5 February 2026, making it one of the country’s largest players in this niche. The firm is registered for Type II Financial Instruments, investment management, and investment advisory businesses and counts major Japanese financial groups—such as Credit Saison, Mizuho, SBI, MUFG Innovation Partners, and others—among its shareholders. HiJoJo’s model aims at the “democratization of startup investing” by giving domestic high-net-worth and retail investors access to private, late-stage equity previously limited to institutions. With the fresh capital, management plans to expand its business foundation, deepen global partnerships, and broaden the range of attractive investment opportunities it can offer clients. The company also envisions listing funds that bundle promising unlisted companies, potentially creating a new domestic trading market for private shares.

Participated · Series C · Feb 2026

Founded in 2016, NIHON AGRI operates a vertically integrated business that spans production, sorting, packaging, and export of Japanese agricultural produce, with a focus on Asian markets such as Taiwan and Hong Kong. The company pioneered high-density planting for apples in Aomori Prefecture, achieving average yields of about 6 tons per 0.1 hectare—three times conventional methods. Its flagship export, Aomori apples, reached 2,761 tons and ¥1.58 billion in value for the 2024 Lunar New Year season. NIHON AGRI now works with 700 directly contracted apple growers, roughly 2.3 × last year, driving a 2.2 × increase in supply volume. Beyond its own orchards, the firm runs “Nichinou Pack,” an agricultural entry support program that guides other companies from business launch through sales of harvested crops. The new capital will fund working capital needs and value-chain investments to scale apple exports and expand Nichinou Pack. To date, the company has raised about ¥5.7 billion in equity financing.

Participated · Equity · Dec 2025

Enlightra is a deep-tech startup building patented multi-colour comb-laser platforms intended to replace power-hungry copper links in AI clusters and data centres with energy-efficient optical communication. Its integrated lasers consolidate many discrete sources into a single chip, with each wavelength acting as an independent data channel, dramatically shrinking power consumption, cost, and physical footprint. Built on industry-standard silicon-photonics processes, the company has already demonstrated 8- and 16-channel devices that achieve error-free data transmission at target speeds and power levels. Enlightra plans pilot production for 2027 and ultimately envisions its technology scaling from GPU-to-GPU links to whole-data-centre networks, subsea cables, and even quantum or space communications. By enabling fibre networks to run closer to full capacity, the platform aims to decouple performance growth from energy and cost increases in AI infrastructure. The fresh capital will fund continued R&D to boost data-transfer rates and efficiency while preparing the lasers for large-scale manufacturing.

Participated · Equity · Nov 2025

Founded in 2020, Iambic Therapeutics integrates pioneering AI models, such as its Enchant multimodal transformer and NeuralPLexer structure predictor, with automated chemistry to run weekly design-make-test cycles. The platform is used to generate differentiated development candidates and has already delivered new drugs into human trials with what the company claims is unprecedented speed. Its lead asset, IAM1363, has shown anti-tumor activity and a favorable safety profile in HER2-wild-type and HER2-mutated cancers, and is now part of a clinical collaboration with Jazz Pharmaceuticals. Additional internal programs targeting KIF18A and CDK2/4 are expected to enter the clinic soon. Iambic is also engaged in a technology-enablement collaboration with Revolution Medicines that pairs proprietary data with NeuralPLexer capabilities. The company advances both wholly owned and partnered pipelines aimed at addressing urgent unmet needs. Backed by a recent oversubscribed financing of more than $100 million, Iambic is positioned to expand its pipeline, partnerships, and platform innovations.

Participated · Series G · Mar 2025

GrubMarket is an AI-driven technology and B2B e-commerce company that digitizes, automates, and streamlines the American and global food supply chain. Its offerings include enterprise SaaS such as an Inventory Management AI Agent and Reporting AI Agent, as well as a tech-enabled marketplace that serves customers in all 50 U.S. states and more than 70 countries. Recent acquisitions—Coast Citrus, Delta Fresh Produce, and Procurant—have expanded its reach; Procurant alone facilitates $5.5 billion in GMV for over 850 customers across 14 countries. The firm operates with what it calls a self-sustaining, profitable model and has been recognized on the CNBC Disruptor 50 list for three consecutive years. It runs the Sustainable California initiative, which promotes organic farming and has funded hundreds of thousands of tree plantings. Backed by a $4.5 billion pre-money valuation, the company plans to invest further in talent, financial infrastructure, technology development, and additional acquisitions to expand across North America, South America, Europe, and Africa.